7 completed. 4 Phase 1, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Not applicable | 2 | Completed 2 |
Follow Recreational Drug Use: new trials by email Literature Review of Recreational Drug Use trials Research Report on Recreational Drug Use
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Teen Connection Project for Trans and Gender Minority Youth Teen Connection Project (TCP) - Recreational Drug Use, Sexual Violence | Not applicable | Completed | University of Michigan | 56 | 2024-07-22 | 2026-05-22 |
| A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104) PF614, Oxycodone Hydrochloride 40 mg, Placebo - Recreational Drug Use | Phase 1 | Completed | Ensysce Biosciences | 32 | 2022-10-05 | 2024-09-24 |
| A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103) PF614, Oxycodone, Placebo - Recreational Drug Use | Phase 1 | Completed | Ensysce Biosciences | 27 | 2022-06-10 | 2024-09-24 |
| Chemsex Engagement and HIV Biomedical Prevention in MSM HIV test - Recreational Drug Use | Completed | Chinese University of Hong Kong | 733 | 2021-06-01 | 2025-01-23 | |
| A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users Lasmiditan, Alprazolam, Placebo - Recreational Drug Use, Prescription Drug Abuse (Not Dependent) | Phase 1 | Completed | Eli Lilly and Company | 96 | 2017-09-15 | 2020-01-10 |
| Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo Placebo, EMBEDA - morphine sulfate/ naltrexone hydrochloride, morphine sulfate CR crushed. - Narcotic Abuse, Opioid-related Disorders | Phase 1 | Completed | Pfizer | 33 | 2010-08-01 | 2012-06-08 |
| Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition. 3,4-methylenedioxymethamphetamine or Placebo - MDMA Discontinuation Syndrome | Not applicable | Completed | California Pacific Medical Center Research Institute | 12 | 2010-04-01 | 2013-05-31 |
Substance-Related Disorders (2) · Agnosia (1) · Alcohol Drinking (1) · Anxiety Disorders (1) · Chronic Pain (1) · Depression (1) · Homosexuality (1) · Narcotic-Related Disorders (1) · Opioid-Related Disorders (1) · Risk-Taking (1) · Sexual Behavior (1) · Suicidal Ideation (1)
Behavior (7) · Mental Disorders (4) · Chemically-Induced Disorders (3) · Behavioral Symptoms (1) · Drinking Behavior (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Perceptual Disorders (1) · Self-Injurious Behavior (1) · Sexual Behavior (1) · Sexuality (1) · Signs and Symptoms (1)
Oxycodone (2) · Tablets (2) · Alprazolam (1) · HIV Testing (1) · N-Methyl-3,4-methylenedioxyamphetamine (1) · Naltrexone (1) · lasmiditan (1)
Ensysce Biosciences (2) · California Pacific Medical Center Research Institute (1) · Chinese University of Hong Kong (1) · Eli Lilly and Company (1) · Pfizer (1) · University of Michigan (1)
United States (5) · Hong Kong (1)
Glen Apseloff, MD, FCP (1) · John Mendelson, MD (1) · Katie M Edwards, PhD (1) · Lynn Kirkpatrick, PhD (1)
R01DA016776 (1)